Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
- DOI
- 10.1186/s13045-017-0484-1
- Published
- 2017-06-19
- Container
- Journal of Hematology & Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-017-0484-1,
title = {Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases},
author = {Melissa García-Caballero and Jenny Paupert and Silvia Blacher and Maureen Van de Velde and Ana Rodríguez Quesada and Miguel Angel Medina and Agnès Noël},
year = {2017},
journal = {Journal of Hematology \& Oncology},
doi = {10.1186/s13045-017-0484-1},
url = {https://doi.org/10.1186/s13045-017-0484-1}
}RIS
TY - JOUR TI - Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases AU - Melissa García-Caballero AU - Jenny Paupert AU - Silvia Blacher AU - Maureen Van de Velde AU - Ana Rodríguez Quesada AU - Miguel Angel Medina AU - Agnès Noël PY - 2017 JO - Journal of Hematology & Oncology DO - 10.1186/s13045-017-0484-1 UR - https://doi.org/10.1186/s13045-017-0484-1 ER -
APA
García-Caballero, M., Paupert, J., Blacher, S., Velde, M. V. D., Quesada, A. R., Medina, M. A., & Noël, A. (2017). Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-017-0484-1
Source records
- crossref · retrieved 2026-11-10T00:51:09.850Z